Marshall Wace’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$394K Sell
1,573
-34,052
-96% -$8.47M ﹤0.01% 2550
2025
Q4
$9.8M Buy
35,625
+34,825
+4,353% +$9.53M 0.01% 880
2025
Q3
$210K Sell
800
-61,726
-99% -$15M ﹤0.01% 2558
2025
Q2
$13.7M Sell
62,526
-103,573
-62% -$22.1M 0.02% 723
2025
Q1
$37.2M Sell
166,099
-61,166
-27% -$16.9M 0.05% 349
2024
Q4
$74.4M Buy
227,265
+99,006
+77% +$31.2M 0.09% 208
2024
Q3
$38.5M Buy
128,259
+80,280
+167% +$24.6M 0.05% 332
2024
Q2
$15.8M Sell
47,979
-327,699
-87% -$116M 0.02% 569
2024
Q1
$149M Buy
375,678
+312,531
+495% +$116M 0.25% 82
2023
Q4
$22.2M Sell
63,147
-90,614
-59% -$32.1M 0.04% 449
2023
Q3
$57.7M Buy
153,761
+114,994
+297% +$44.5M 0.12% 177
2023
Q2
$14.8M Sell
38,767
-19,272
-33% -$6.88M 0.03% 588
2023
Q1
$20.1M Buy
58,039
+56,983
+5,396% +$16.7M 0.05% 465
2022
Q4
$249K Sell
1,056
-112,121
-99% -$26.6M ﹤0.01% 2628
2022
Q3
$27.8M Buy
113,177
+87,634
+343% +$26.7M 0.07% 346
2022
Q2
$7.72M Buy
+25,543
New +$8.31M 0.02% 1049
2022
Q1
Sell
-199
Closed -$93K 4185
2021
Q4
$93K Sell
199
-248,900
-100% -$107M ﹤0.01% 3399
2021
Q3
$106M Buy
249,099
+93,783
+60% +$39.5M 0.52% 25
2021
Q2
$55.8M Buy
+155,316
New +$51.3M 0.29% 68
2020
Q4
Sell
-10,445
Closed -$2.87M 2232
2020
Q3
$2.87M Sell
10,445
-1,767
-14% -$468K 0.02% 704
2020
Q2
$2.77M Buy
+12,212
New +$2.4M 0.02% 665
2020
Q1
Sell
-10,825
Closed -$1.63M 2101
2019
Q4
$1.63M Sell
10,825
-17,926
-62% -$2.61M 0.01% 866
2019
Q3
$4.08M Buy
+28,751
New +$3.96M 0.03% 562
2019
Q2
Sell
-80,140
Closed -$8.83M 1901
2019
Q1
$8.83M Buy
+80,140
New +$8.34M 0.08% 298
2018
Q4
Sell
-99,369
Closed -$12.3M 1841
2018
Q3
$12.3M Buy
99,369
+85,464
+615% +$9.58M 0.1% 260
2018
Q2
$1.38M Buy
+13,905
New +$1.28M 0.02% 471
2016
Q3
Sell
-8,500
Closed -$645K 1157
2016
Q2
$645K Sell
8,500
-27,938
-77% -$2.03M 0.01% 788
2016
Q1
$2.53M Buy
+36,438
New +$2.19M 0.02% 508

Other funds holding WST